Leaflet FAVIRAB 200-400UI / ml solution for injection
Indicated for: immunosuppression
Route of administration: injectable
Substance: equine rabies immunoglobulin (immunoglobulin)
ATC: J06BB05 (Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Equine rabies immunoglobulin is a product derived from horse serum used to prevent rabies in individuals exposed to the rabies virus, usually through bites from infected animals. It provides passive immunity by supplying pre-formed antibodies against the rabies virus.
The medication is administered via intramuscular injection, as directed by a doctor, and is used in combination with the rabies vaccine.
Side effects may include pain at the injection site, fever, allergic reactions, or, in rare cases, anaphylactic reactions.
Patients should inform their doctor about any known allergies or other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
General data about FAVIRAB 200-400UI / ml
- Substance: equine rabies immunoglobulin
- Date of latest medicines list: 01-07-2020
- Product code: W59154002
- Concentration: 200-400UI / ml
- Pharmaceutical form: solution for injection
- Quantity: 10
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.